THE USE OF A SYNTHETIC ANALOGUE OF POSTHYPOPHYSIAL VASOPRESSIN (PLV-2) FOR LOCAL HEMOSTASIS.
D035843:Biomedical Research; D004358:Drug Therapy; D004837:Epinephrine; D005259:Felypressin; D005260:Female; D005264:Femoral Fractures; D006487:Hemostasis; D006801:Humans; D007044:Hysterectomy; D007279:Injections, Subcutaneous; D007440:Intubation; D007442:Intubation, Intratracheal; D008239:Lysine; D014663:Nasal Decongestants; D009297:Nasal Mucosa; D011300:Preoperative Care; D014116:Toxicology; D014662:Vasoconstrictor Agents; D014667:Vasopressins
D014663:Nasal Decongestants; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D005259:Felypressin; D008239:Lysine; D004837:Epinephrine
CLINICAL RESEARCH; DRUG THERAPY; EPINEPHRINE; FEMORAL FRACTURES; HEMOSTASIS; HYSTERECTOMY; INJECTIONS, SUBCUTANEOUS; INTUBATION, INTRATRACHEAL; LYSINE; NASAL MUCOSA; PHELYPRESSIN; PREOPERATIVE CARE; TOXICOLOGIC REPORT; VASOCONSTRICTOR AGENTS; VASOCONSTRICTOR AGENTS, NASAL; VASOPRESSIN